Skip to main content
Clinical Trials/NCT01781923
NCT01781923CompletedNot Applicable

A Remediation Program for Children at High-Risk of Schizophrenia: 22q11.2 Deletion Syndrome

Duke University2 sites in 1 country38 target enrollmentStarted: October 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
38
Locations
2
Primary Endpoint
Change in sustained attention

Study Overview

Brief Summary

The goal of this study is to collect preliminary data on the efficacy of a cognitive remediation program in improving the neurocognitive deficits in children with chromosome 22q11.2 deletion syndrome (22q11DS). This study involves a two part approaching including a computerized cognitive remediation program (CCRP, Posit Science, CA) in combination with a Social Cognitive Training (SCT) program. The computer-based training program has shown encouraging results in improving learning deficits in individuals with schizophrenia and we now seek to adapt them to children with 22q11DS, who have unique needs due to their lower IQ and high risk of psychosis in late adolescence and adulthood. The SCT is a small-group intervention program based on cognitive enhancement therapy, which has been shown to improve social cognition and functionality in adults with schizophrenia. A preliminary study will be performed using this two-pronged approach, to establish the feasibility and gather preliminary data on neurocognition before and after the intervention in these children; these data would enable a larger randomized controlled study to assess the efficacy of this approach.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Masking
None

Eligibility Criteria

Ages
11 Years to 17 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • molecular/cytogenetic confirmation of 22q11DS

Exclusion Criteria

  • Intelligence Quotient <60
  • diagnosis of psychosis
  • pregnancy
  • home location does not permit participation in small groups

Outcomes

Primary Outcomes

Change in sustained attention

Time Frame: Baseline and 12 weeks

Sustained attention will be assessed using the Continuous Performance Test.

Change in executive function.

Time Frame: Baseline and 12 weeks

Change in verbal memory.

Time Frame: Baseline and 12 weeks

Secondary Outcomes

  • Social skills(40 weeks)
  • Change in brain function and white matter structure.(Baseline and 12 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials